Latest China Market News

Audeara Ltd reported a strong Q2 FY26 with revenues up 274% year-on-year, securing key regulatory approval in China and expanding its global licensing footprint.

Osteopore Limited has inked an exclusive collaboration with Majeton to commercialise its cutting-edge 3D-printed bioresorbable implants across China, Hong Kong, and Macau, unlocking significant growth potential in the region.

Nova Eye Medical has reported a record US$6.1 million in sales for the December 2025 quarter, driven by strong US demand and a 24% annual growth rate that outpaces the industry.

Treasury Wine Estates moderates its first-half fiscal 2026 outlook due to softer US and China markets, unveiling a major transformation program targeting $100 million in annual cost savings starting next year.

Treasury Wine Estates moderates growth forecasts due to softening demand in key US and China markets, unveiling a major transformation program and cost-saving measures to safeguard brand strength and profitability.

Merino & Co. has secured a significant new order from its Shanghai distribution partner, reinforcing its expanding footprint in China’s luxury apparel market and validating its strategic growth plans.

RooLife Group's RLG Coffee brand has rapidly scaled to over A$1 million in sales in China just months after launch, supported by a substantial A$64 million supply agreement.

The a2 Milk Company has secured key regulatory approvals in China, moving closer to launching its infant formula products under the a2MC brand by mid-2027.

Nufarm Limited posted a $165.3 million statutory loss for FY25, driven by significant restructuring charges and omega-3 price declines, while announcing a CEO transition effective January 2026.

Merino & Co. initiates a new chapter with leadership changes and a strategic partnership to enter China’s premium apparel market, while investing heavily in growth during Q1 FY26.

Nova Eye Medical reported a robust 32% increase in global sales excluding China for Q1 FY26 and secured regulatory approval for its iTrack™ Advance device in China, setting the stage for expanded market penetration.

CurveBeam AI reports a 33% increase in Q1 FY26 purchase orders, secures A$6.5 million in new funding, and finalizes a strategic joint venture for China distribution and manufacturing rights.